Re-Purposing Dronabinol Using Proprietary Formulations for New Therapeutic Indications, Specifically Obstructive Sleep Apnea (OSA)
Time: 10:00 am
day: Conference Day 1
Details:
- Looking at Dronabinol’s potential to stabilize respiratory patterns and augment upper airway muscles
- Introducing drug formulation innovation in the form of proprietary lipid nanoparticle technology to enhance solubility and absorption
- Enhancing Dronabinol stability and ease of manufacturing to support commercial scale
